314 related articles for article (PubMed ID: 15930313)
1. Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-kappaB activation.
Farhana L; Dawson MI; Fontana JA
Cancer Res; 2005 Jun; 65(11):4909-17. PubMed ID: 15930313
[TBL] [Abstract][Full Text] [Related]
2. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
Farhana L; Dawson MI; Murshed F; Fontana JA
Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
[TBL] [Abstract][Full Text] [Related]
3. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
4. SHP and Sin3A expression are essential for adamantyl-substituted retinoid-related molecule-mediated nuclear factor-kappaB activation, c-Fos/c-Jun expression, and cellular apoptosis.
Farhana L; Dawson MI; Dannenberg JH; Xu L; Fontana JA
Mol Cancer Ther; 2009 Jun; 8(6):1625-35. PubMed ID: 19509248
[TBL] [Abstract][Full Text] [Related]
5. NF-κB p65 recruited SHP regulates PDCD5-mediated apoptosis in cancer cells.
Murshed F; Farhana L; Dawson MI; Fontana JA
Apoptosis; 2014 Mar; 19(3):506-17. PubMed ID: 24343129
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
7. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.
Ravi R; Bedi GC; Engstrom LW; Zeng Q; Mookerjee B; Gélinas C; Fuchs EJ; Bedi A
Nat Cell Biol; 2001 Apr; 3(4):409-16. PubMed ID: 11283615
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
[TBL] [Abstract][Full Text] [Related]
9. Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.
Cavin LG; Venkatraman M; Factor VM; Kaur S; Schroeder I; Mercurio F; Beg AA; Thorgeirsson SS; Arsura M
Cancer Res; 2004 Oct; 64(19):7030-8. PubMed ID: 15466196
[TBL] [Abstract][Full Text] [Related]
10. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities.
Farhana L; Dawson MI; Huang Y; Zhang Y; Rishi AK; Reddy KB; Freeman RS; Fontana JA
Oncogene; 2004 Mar; 23(10):1874-84. PubMed ID: 14981538
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.
Soares MP; Muniappan A; Kaczmarek E; Koziak K; Wrighton CJ; Steinhäuslin F; Ferran C; Winkler H; Bach FH; Anrather J
J Immunol; 1998 Nov; 161(9):4572-82. PubMed ID: 9794384
[TBL] [Abstract][Full Text] [Related]
13. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
15. Antagonist analogue of 6-[3'-(1-adamantyl)-4'-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest.
Dawson MI; Harris DL; Liu G; Hobbs PD; Lange CW; Jong L; Bruey-Sedano N; James SY; Zhang XK; Peterson VJ; Leid M; Farhana L; Rishi AK; Fontana JA
J Med Chem; 2004 Jul; 47(14):3518-36. PubMed ID: 15214780
[TBL] [Abstract][Full Text] [Related]
16. Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xL.
Mora AL; Corn RA; Stanic AK; Goenka S; Aronica M; Stanley S; Ballard DW; Joyce S; Boothby M
Cell Death Differ; 2003 Sep; 10(9):1032-44. PubMed ID: 12934078
[TBL] [Abstract][Full Text] [Related]
17. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
Kim HS; Chang I; Kim JY; Choi KH; Lee MS
Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL).
Robbins MA; Maksumova L; Pocock E; Chantler JK
Endocrinology; 2003 Oct; 144(10):4616-25. PubMed ID: 12960048
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt.
Han YH; Cao X; Lin B; Lin F; Kolluri SK; Stebbins J; Reed JC; Dawson MI; Zhang XK
Oncogene; 2006 May; 25(21):2974-86. PubMed ID: 16434970
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog.
Zhang Y; Dawson MI; Ning Y; Polin L; Parchment RE; Corbett T; Mohamed AN; Feng KC; Farhana L; Rishi AK; Hogge D; Leid M; Peterson VJ; Zhang XK; Mohammad R; Lu JS; Willman C; VanBuren E; Biggar S; Edelstein M; Eilender D; Fontana JA
Blood; 2003 Nov; 102(10):3743-52. PubMed ID: 12893763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]